These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17192048)

  • 1. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
    Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
    Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.
    Manne U; Jhala NC; Jones J; Weiss HL; Chatla C; Meleth S; Suarez-Cuervo C; Grizzle WE
    Clin Cancer Res; 2004 Mar; 10(5):1743-52. PubMed ID: 15014027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of mucin 4 expression in colorectal adenocarcinomas.
    Shanmugam C; Jhala NC; Katkoori VR; Wan W; Meleth S; Grizzle WE; Manne U
    Cancer; 2010 Aug; 116(15):3577-86. PubMed ID: 20564074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior.
    Shanmugam C; Katkoori VR; Jhala NC; Grizzle WE; Siegal GP; Manne U
    J Histochem Cytochem; 2008 Mar; 56(3):305-12. PubMed ID: 18071066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival.
    Nicholson AD; Guo X; Sullivan CA; Cha CH
    J Am Coll Surg; 2014 Nov; 219(5):977-87. PubMed ID: 25127509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
    Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
    Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
    Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
    Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers.
    Lee JA; Park HE; Jin HY; Jin L; Cho NY; Bae JM; Kim JH; Kang GH
    Ann Diagn Pathol; 2024 Aug; 71():152289. PubMed ID: 38555678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.